Skip to main content
Top
Published in: Journal of Endocrinological Investigation 9/2014

01-09-2014 | Original Article

Vitamin D levels in a paediatric population of normal weight and obese subjects

Authors: S. Bellone, S. Esposito, E. Giglione, G. Genoni, C. Fiorito, A. Petri, G. Bona, F. Prodam

Published in: Journal of Endocrinological Investigation | Issue 9/2014

Login to get access

Abstract

Background

Vitamin D exerts pleiotropic effects and few studies are available in the Italian population.

Aim

Aim of our study was to evaluate vitamin D status in children living in Northern Italy.

Methods

We studied vitamin D levels in a population of 113 normal weight (NW) and 444 obese (OB) children, prepubertal and pubertal. We considered vitamin D levels >20 ng/ml as normal, but also measured percentage of children with vitamin D levels higher than a cutoff of 30 ng/ml.

Results

68.2 % of NW children showed normal levels of vitamin D, while 31.8 % showed a clear vitamin D deficiency. Only 28.3 % showed vitamin D levels higher than 30 ng/ml. Obese children showed 55.6 % of subjects with normal levels of vitamin D and 44.4 % of subjects a status of vitamin D deficiency. Only the 18.9 % showed vitamin D levels higher than 30 ng/ml. Mean vitamin D levels in NW children (27.3 ± 1.2 ng/ml) were higher than in OB children (21.8 ± 0.6 ng/ml). No differences have been found between prepubertal and pubertal children in terms of vitamin D levels.

Conclusions

Our paediatric population demonstrates a low percentage of vitamin D sufficiency. In particular, obese children show only 19 % of subjects with normal levels while almost half of this population shows a clear deficiency. Further studies are needed to support these results and to evaluate the possible metabolic consequences.
Literature
1.
go back to reference Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124:362–370CrossRef Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124:362–370CrossRef
3.
go back to reference Arabi A, El Rassi R, El-Hajj Fuleihan G (2010) Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 6:550–561PubMedCrossRef Arabi A, El Rassi R, El-Hajj Fuleihan G (2010) Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol 6:550–561PubMedCrossRef
4.
go back to reference Hazell TJ, DeGuire JR, Weiler HA (2012) Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescent. Nutr Rev 70:520–533PubMedCrossRef Hazell TJ, DeGuire JR, Weiler HA (2012) Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescent. Nutr Rev 70:520–533PubMedCrossRef
5.
go back to reference Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M, Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122:398–417PubMedCrossRef Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M, Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122:398–417PubMedCrossRef
6.
go back to reference Marrone G, Rosso I, Moretti R, Valent F, Romanello C (2012) Is vitamin D status known among children living in Northern Italy? Eur J Nutr 51:143–149PubMedCrossRef Marrone G, Rosso I, Moretti R, Valent F, Romanello C (2012) Is vitamin D status known among children living in Northern Italy? Eur J Nutr 51:143–149PubMedCrossRef
7.
go back to reference Alemzadeh R, Kichler J, Babar G, Calhoun M (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57:183–191PubMedCrossRef Alemzadeh R, Kichler J, Babar G, Calhoun M (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57:183–191PubMedCrossRef
8.
go back to reference Zgaga L, Theodoratou E, Farrington SM et al (2011) Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient. J Nutr 141:1535–1542PubMedCentralPubMedCrossRef Zgaga L, Theodoratou E, Farrington SM et al (2011) Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient. J Nutr 141:1535–1542PubMedCentralPubMedCrossRef
9.
go back to reference Holick MF, Binkley MC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930PubMedCrossRef Holick MF, Binkley MC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930PubMedCrossRef
10.
12.
go back to reference Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B et al (2013) Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the US Nationally Representative NHANES. J Clin Endocrinol Metab 98:3001–3009PubMedCentralPubMedCrossRef Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B et al (2013) Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the US Nationally Representative NHANES. J Clin Endocrinol Metab 98:3001–3009PubMedCentralPubMedCrossRef
13.
go back to reference Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all cause mortality in older US adults. J Am Geriatr Soc 57:1595–1603PubMedCrossRef Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all cause mortality in older US adults. J Am Geriatr Soc 57:1595–1603PubMedCrossRef
14.
go back to reference Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS (2011) Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev 19:192–201PubMedCrossRef Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS (2011) Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev 19:192–201PubMedCrossRef
15.
go back to reference Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58PubMedCentralPubMedCrossRef Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58PubMedCentralPubMedCrossRef
16.
go back to reference Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed
17.
go back to reference Maguire JL, Birken C, Thorpe KE, Sochett EB, Parkin PC (2014) Parathyroid hormone as a functional indicator of vitamin d sufficiency in children. JAMA Pediatrics 168:383–385PubMedCrossRef Maguire JL, Birken C, Thorpe KE, Sochett EB, Parkin PC (2014) Parathyroid hormone as a functional indicator of vitamin d sufficiency in children. JAMA Pediatrics 168:383–385PubMedCrossRef
18.
go back to reference Cacciari E, Milani S, Balsamo A et al (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593PubMedCrossRef Cacciari E, Milani S, Balsamo A et al (2006) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581–593PubMedCrossRef
19.
go back to reference Turer CB, Lin H, Flores G (2013) Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 131:152–161CrossRef Turer CB, Lin H, Flores G (2013) Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 131:152–161CrossRef
20.
go back to reference Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103:204–205PubMedCentralPubMedCrossRef Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103:204–205PubMedCentralPubMedCrossRef
21.
go back to reference Rovner AJ, O’ Brien KO (2008) Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med 162:513–519PubMedCrossRef Rovner AJ, O’ Brien KO (2008) Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med 162:513–519PubMedCrossRef
22.
go back to reference El-Hajj Fuleihan G, Nabulsi M, Tamim H et al (2006) Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab 91:405–412PubMedCrossRef El-Hajj Fuleihan G, Nabulsi M, Tamim H et al (2006) Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab 91:405–412PubMedCrossRef
24.
go back to reference Cheng S, Tylavsky F, Kroger H et al (2003) Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr 78:485–492PubMed Cheng S, Tylavsky F, Kroger H et al (2003) Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr 78:485–492PubMed
25.
go back to reference Pekkinen M, Viljakainen H, Saarnio E, Lamberg-Allardt C, Mäkitie O (2012) Vitamin D is a major determinant of bone mineral density at school age. PLoS One 7:e40090PubMedCentralPubMedCrossRef Pekkinen M, Viljakainen H, Saarnio E, Lamberg-Allardt C, Mäkitie O (2012) Vitamin D is a major determinant of bone mineral density at school age. PLoS One 7:e40090PubMedCentralPubMedCrossRef
26.
go back to reference Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M (2011) Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 96:1320–1326PubMedCentralPubMedCrossRef Grethen E, McClintock R, Gupta CE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M (2011) Vitamin D and hyperparathyroidism in obesity. J Clin Endocrinol Metab 96:1320–1326PubMedCentralPubMedCrossRef
27.
go back to reference Hollis BW, Wagner CL (2013) The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98:4619–4628PubMedCrossRef Hollis BW, Wagner CL (2013) The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98:4619–4628PubMedCrossRef
28.
go back to reference Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, Acton A, Considine RV, Peacock M (2012) Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 97:1655–1662PubMedCentralPubMedCrossRef Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, Acton A, Considine RV, Peacock M (2012) Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 97:1655–1662PubMedCentralPubMedCrossRef
29.
go back to reference Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obesity 37:387–396CrossRef Earthman CP, Beckman LM, Masodkar K, Sibley SD (2012) The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obesity 37:387–396CrossRef
30.
go back to reference Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W (2004) Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19:265–269PubMedCrossRef Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W (2004) Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19:265–269PubMedCrossRef
31.
go back to reference Zanello LP, Norman AW (2004) Rapid modulation of osteoblast ion channel responses by 1 alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101:1589–1594PubMedCentralPubMedCrossRef Zanello LP, Norman AW (2004) Rapid modulation of osteoblast ion channel responses by 1 alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101:1589–1594PubMedCentralPubMedCrossRef
32.
go back to reference Ceglia L (2008) Vitamin D and skeletal muscle tissue and function. Mol Asp Med 29:407–414CrossRef Ceglia L (2008) Vitamin D and skeletal muscle tissue and function. Mol Asp Med 29:407–414CrossRef
33.
go back to reference Reis JP, von Muhlen D, Miller ER 3rd (2008) Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159:41–48PubMedCrossRef Reis JP, von Muhlen D, Miller ER 3rd (2008) Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159:41–48PubMedCrossRef
34.
go back to reference Lu L, Yu Z, Pan A et al (2009) Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32:1278–1283PubMedCentralPubMedCrossRef Lu L, Yu Z, Pan A et al (2009) Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32:1278–1283PubMedCentralPubMedCrossRef
35.
go back to reference Vimaleswaran KS, Berry DJ, Lu C et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. Plos Med 10:e1001383PubMedCentralPubMedCrossRef Vimaleswaran KS, Berry DJ, Lu C et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. Plos Med 10:e1001383PubMedCentralPubMedCrossRef
Metadata
Title
Vitamin D levels in a paediatric population of normal weight and obese subjects
Authors
S. Bellone
S. Esposito
E. Giglione
G. Genoni
C. Fiorito
A. Petri
G. Bona
F. Prodam
Publication date
01-09-2014
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 9/2014
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0108-3

Other articles of this Issue 9/2014

Journal of Endocrinological Investigation 9/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.